Drug-Drug Interaction (DDI) Study of Leramistat in Healthy Adult Subjects

Launched by MODERN BIOSCIENCES LTD · Apr 17, 2024

Keywords

ClinConnect Summary

This clinical trial is studying how a new drug called Leramistat interacts with other medications in healthy adults. The trial is designed to help researchers understand how the body processes Leramistat and if it changes when taken with other drugs. It is an early-phase study, which means it is one of the first steps in testing this drug's effects in humans.

To participate in this trial, you must be a healthy adult aged between 18 and 55 years, and both men and women can join. However, if you have any significant medical or mental health conditions or if you have had any illnesses that could affect the study’s results, you may not be eligible. Participants can expect to be in a controlled environment where they will receive the drug and be monitored closely for any effects. This study is currently looking for participants, and it’s a great opportunity to contribute to important research in medicine.

Gender

ALL

Eligibility criteria

• Principal Inclusion Criteria:
• • Healthy, adult, male or female of non childbearing potential 18 to 55 years of age.
• Principal Exclusion Criteria:
• • History or presence of clinically significant medical or psychiatric condition or disease in the opinion of the PI or designee.
• • History of any illness that, in the opinion of the PI or designee, might confound the results of the study or poses an additional risk to the subject by their participation in the study.